Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Deep Learning
100%
Receptor Agonist
50%
Omics
50%
A1 Receptor
50%
Patients with Obesity
50%
Receptor mutations
50%
Biotechnology
50%
Melanocortin 4 Receptor (MC4R)
50%
Glucagon-like
50%
Multi-omics
50%
Liraglutide
35%
Multimodal Data
33%
Copenhagen
25%
University of Copenhagen
25%
Faculty of Health Sciences
25%
Research Faculty
25%
Protein Research
25%
Denmark
25%
University of Medical Sciences
25%
Novo Nordisk
25%
In Silico Perturbation
16%
Gut Microbiota
16%
Response to Treatment
16%
Statistical Test
16%
Atorvastatin
16%
Multiple Omics
16%
Drug Effects
16%
Patient-level
16%
Statins
16%
Metformin
16%
Disease Pattern
16%
Polypharmacy
16%
High Sensitivity
16%
New-onset Type 2 Diabetes
16%
Omics Technologies
16%
Variational Autoencoder
16%
Simvastatin
16%
Molecular Response
16%
Monogenic Obesity
14%
Reduction Effect
7%
Liraglutide 3.0 Mg
7%
Most Common Form
7%
Obese Men
7%
Total Body Fat
7%
Limited Treatment Options
7%
Waist Circumference
7%
Pathogenic mutations
7%
Massive Weight Loss
7%
Most Common Cause
7%
Biochemistry, Genetics and Molecular Biology
Statistical Test
50%
Phenotype
50%
Glucagon-Like Peptide 1 Receptor
50%
Receptor Agonists
50%
Statin
50%
Intestine Flora
50%
Simvastatin
50%
Melanocortin 4 Receptor
50%
Drug Effect
50%
Atorvastatin
50%
Computer Model
50%
Liraglutide
42%
Body Fat
7%
Waist Circumference
7%
Body Weight
7%
